2022
DOI: 10.1038/s41591-022-01862-8
|View full text |Cite|
|
Sign up to set email alerts
|

Regenerative and restorative medicine for eye disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 52 publications
(27 citation statements)
references
References 73 publications
0
17
0
Order By: Relevance
“…1 Over the last two decades, numerous strategies have emerged, including gene replacement therapy, 2 gene editing approaches, 3 optogenetics, 4 retinal electrical implants, 5 induced pluripotent stem cell (iPSC)-derived retinal cell replacements, 6 and pharmacological agents. [7][8][9] These approaches can restore light-sensing ability at the retinal level and lead to improvements in visual perception in patients to varying extents. Studies of synthetic retinoid treatment in patients with RPE65 or LRAT mutations have led to improvements in visual field area and visual cortex activation, as seen on fMRI scans.…”
Section: Resultsmentioning
confidence: 99%
“…1 Over the last two decades, numerous strategies have emerged, including gene replacement therapy, 2 gene editing approaches, 3 optogenetics, 4 retinal electrical implants, 5 induced pluripotent stem cell (iPSC)-derived retinal cell replacements, 6 and pharmacological agents. [7][8][9] These approaches can restore light-sensing ability at the retinal level and lead to improvements in visual perception in patients to varying extents. Studies of synthetic retinoid treatment in patients with RPE65 or LRAT mutations have led to improvements in visual field area and visual cortex activation, as seen on fMRI scans.…”
Section: Resultsmentioning
confidence: 99%
“…The demonstration of measurable acuity from photoswitch-treated rd1 retinas suggests that the EyeCandy system may be used to estimate and compare the effects of vision restoration methodologies, such as stem cell photoreceptor replacement, 44 small molecule photoswitches, optogenetic gene therapy, 45 and opto-electronic stimulation 46 on potential acuity ex vivo. In the current work, we show proof of concept for the photoswitch BENAQ, 47 but several other photoswitches with varying cell targets in the retina remain to be tested.…”
Section: Discussionmentioning
confidence: 99%
“…The latter compound could then be subjected to an anion metathesis using a saturated aqueous solution of KPF 6 to afford BDHPPy + , PF 6 − (92%). The structures of these compounds were confirmed by 1 H and 13 C nuclear magnetic resonance (NMR) spectroscopy methods as well as mass spectrometry analyses (see the Experimental Section and the Supporting Information).…”
Section: Synthesesmentioning
confidence: 97%
“…Infrared spectra were recorded on a PerkinElmer Spectrum Two Fourier transform infrared spectrometer using attenuated total reflexion modes. 1 H NMR and 13 C NMR spectra were recorded on a Bruker Avance 500 or 400 MHz spectrometer in CDCl 3 or CD 3 CN. Chemical shifts are calibrated to residual solvent peaks.…”
Section: General Procedures and Instrumentationmentioning
confidence: 99%